Literature DB >> 30279235

Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?

Ted J Kaptchuk1, Franklin G Miller2.   

Abstract

Mesh:

Year:  2018        PMID: 30279235      PMCID: PMC6889847          DOI: 10.1136/bmj.k3889

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  27 in total

1.  Active albuterol or placebo, sham acupuncture, or no intervention in asthma.

Authors:  Michael E Wechsler; John M Kelley; Ingrid O E Boyd; Stefanie Dutile; Gautham Marigowda; Irving Kirsch; Elliot Israel; Ted J Kaptchuk
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

2.  Open-Label Placebo: Reflections on a Research Agenda.

Authors:  Ted J Kaptchuk
Journal:  Perspect Biol Med       Date:  2018       Impact factor: 1.416

3.  Altered placebo and drug labeling changes the outcome of episodic migraine attacks.

Authors:  Slavenka Kam-Hansen; Moshe Jakubowski; John M Kelley; Irving Kirsch; David C Hoaglin; Ted J Kaptchuk; Rami Burstein
Journal:  Sci Transl Med       Date:  2014-01-08       Impact factor: 17.956

4.  Nonconscious activation of placebo and nocebo pain responses.

Authors:  Karin B Jensen; Ted J Kaptchuk; Irving Kirsch; Jacqueline Raicek; Kara M Lindstrom; Chantal Berna; Randy L Gollub; Martin Ingvar; Jian Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 5.  Genetics and the placebo effect: the placebome.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Trends Mol Med       Date:  2015-04-14       Impact factor: 11.951

6.  Patients' attitudes about the use of placebo treatments: telephone survey.

Authors:  Sara Chandros Hull; Luana Colloca; Andrew Avins; Nancy P Gordon; Carol P Somkin; Ted J Kaptchuk; Franklin G Miller
Journal:  BMJ       Date:  2013-07-02

7.  Dopamine, affordance and active inference.

Authors:  Karl J Friston; Tamara Shiner; Thomas FitzGerald; Joseph M Galea; Rick Adams; Harriet Brown; Raymond J Dolan; Rosalyn Moran; Klaas Enno Stephan; Sven Bestmann
Journal:  PLoS Comput Biol       Date:  2012-01-05       Impact factor: 4.475

8.  How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys.

Authors:  Klaus Linde; Oxana Atmann; Karin Meissner; Antonius Schneider; Ramona Meister; Levente Kriston; Christoph Werner
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

Review 9.  Symptom perception, placebo effects, and the Bayesian brain.

Authors:  Giulio Ongaro; Ted J Kaptchuk
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

10.  Open-label placebo treatment in chronic low back pain: a randomized controlled trial.

Authors:  Cláudia Carvalho; Joaquim Machado Caetano; Lidia Cunha; Paula Rebouta; Ted J Kaptchuk; Irving Kirsch
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

View more
  27 in total

1.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

2.  Open-label placebo clinical trials: is it the rationale, the interaction or the pill?

Authors:  Charlotte R Blease; Michael H Bernstein; Cosima Locher
Journal:  BMJ Evid Based Med       Date:  2019-06-26

3.  Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery.

Authors:  Valerie Hruschak; K Mikayla Flowers; Megan Patton; Victoria Merchantz; Emily Schwartz; Robert Edwards; Ted Kaptchuk; James Kang; Michelle Dossett; Kristin Schreiber
Journal:  Int J Behav Med       Date:  2022-08-01

4.  Placebos in clinical care: a suggestion beyond the evidence.

Authors:  Christopher G Maher; Adrian C Traeger; Christina Abdel Shaheed; Mary O'Keeffe
Journal:  Med J Aust       Date:  2021-09-19       Impact factor: 12.776

5.  Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control.

Authors:  Leon Morales-Quezada; Ines Mesia-Toledo; Anayali Estudillo-Guerra; Kevin C O'Connor; Jeffrey C Schneider; Douglas J Sohn; David M Crandell; Ted Kaptchuk; Ross Zafonte
Journal:  Pain Rep       Date:  2020-07-20

6.  Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients.

Authors:  Michael H Bernstein; Nathaniel Fuchs; Maayan Rosenfield; Arnold-Peter Weiss; Charlotte Blease; Cosima Locher; Molly Magill; Josiah Rich; Francesca L Beaudoin
Journal:  J Pain       Date:  2021-05-15       Impact factor: 5.820

7.  A Conversation with … Ted J. Kaptchuk, Expert in Placebo Effects.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2021-08-01       Impact factor: 4.755

8.  Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.

Authors:  Anthony Lembo; John M Kelley; Judy Nee; Sarah Ballou; Johanna Iturrino; Vivian Cheng; Vikram Rangan; Jesse Katon; William Hirsch; Irving Kirsch; Kathryn Hall; Roger B Davis; Ted J Kaptchuk
Journal:  Pain       Date:  2021-09-01       Impact factor: 7.926

9.  Placebos without deception reduce self-report and neural measures of emotional distress.

Authors:  Darwin A Guevarra; Jason S Moser; Tor D Wager; Ethan Kross
Journal:  Nat Commun       Date:  2020-07-29       Impact factor: 14.919

10.  Does Health Literacy Make a Difference? Comparing the Effect of Conventional Medicine Versus Homeopathic Prescribing on Treatment Credibility and Expectancy.

Authors:  Marcel Wilhelm; Frank Euteneuer
Journal:  Front Psychol       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.